Women now live 30 years or more, perhaps a quarter to a third of their lives, after menopause. Improving the quality of those years has become an important health-care goal. Reflecting this, physicians and patients have more treatment options and the search for bone-building drugs continues. Drawing on the expertise of a distinguished international team, The Year in Osteoporosis 2004 contains 200 recent papers selected from the peer- reviewed literature that are most likely to modify the clinical management of the osteoporotic patient. Each paper is summarized, reviewed, and placed in clinical context. The chapter authors explore not only the underlying causes of osteoporosis but the latest differing views on prevention and non-pharmacological strategies. They include a detailed examination of the newest drugs and the possibilities of further pharmaceutical advances. The book provides a comprehensive overview of the latest clinical research, carefully assessed and put into context by an expert panel of authors.

Drawing on the expertise of a distinguished international team, this book contains 200 recent papers in the peer-reviewed literature that will affect the practice of physicians managing osteoporotic patients. Each paper is summarized, reviewed, and placed in clinical context. Coverage includes the underlying causes of osteoporosis and the latest differing views on prevention and non-pharmacological strategies. The book also reviews new drugs and the possibilities of further pharmaceutical advances. It provides a comprehensive overview of the latest clinical research, carefully assessed and put into clinical context.